Loading
journalsJournal
Cancer metastasis reviews
Cancer and Metastasis Reviews is a Springer review journal on how cancers grow, spread and resist treatment, and on the biology behind new therapies. Read by researchers who want authoritative overviews rather than primary data.
Also called: Cancer Metastasis RevCancer and Metastasis ReviewsCancer Metastasis Reviews
Overview
Cancer and Metastasis Reviews (catalogued by NLM as Cancer Metastasis Reviews) is a quarterly Springer review journal founded in 1982, originally with Martinus Nijhoff; its founding editors are listed as Isaiah J. Fidler, Garth L. Nicolson and George Poste. It aims to highlight recent significant advances in basic, translational and clinical cancer research, emphasising studies with high impact for the control of cancer. Topics named on its aims page include oncogenes and tumour suppressors, cell death regulation, DNA repair, immune defects, the microbiome, cell metabolism, genetic and epigenetic alterations, the tumour microenvironment, targeted therapies and immunotherapies, biomarkers, early detection technologies and cancer disparities. It is a hybrid journal with open access funding options. Indexed in MEDLINE.
Publisher
Springer
Scope
cancer biology and metastasis
Access model
hybrid
Founded
1982
ISSN
0167-7659
meta analysis2017172 citations
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
The prevalence estimate that made HER2 the first gallbladder-relevant target; it argues for testing every advanced gallbladder cancer, since one in five may qualify for zanidatamab or trastuzumab deruxtecan.
observational19893,075 citations
The distribution of secondary growths in cancer of the breast. 1889
One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
meta analysisCancer Metastasis Reviews 2017172 citations
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
The prevalence estimate that made HER2 the first gallbladder-relevant target; it argues for testing every advanced gallbladder cancer, since one in five may qualify for zanidatamab or trastuzumab deruxtecan.
observationalCancer metastasis reviews 19893,075 citations
The distribution of secondary growths in cancer of the breast. 1889
One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Similar pages
- JournalClinical & experimental metastasis
Shares Hallmark: activating invasion and metastasis, Metastasis, PubMed & Europe PMC.
- Key paperLamouille 2014: molecular mechanisms of epithelial-mesenchymal transition
Shares Hallmark: activating invasion and metastasis, Metastasis.
- Key paperThiery 2002: epithelial-mesenchymal transitions in tumour progression
Shares Hallmark: activating invasion and metastasis, Metastasis.
- TermInvasive
Shares Hallmark: activating invasion and metastasis, Metastasis.
- JournalOncology reports
Shares Metastasis, PubMed & Europe PMC.
- Key paperKalluri and Weinberg 2009: the basics of epithelial-mesenchymal transition
Shares Hallmark: activating invasion and metastasis, Metastasis.
- JournalCancer letters
Shares Metastasis, PubMed & Europe PMC.
- JournalOncogene
Shares Metastasis, PubMed & Europe PMC.